N2 Biomedical appoints new CEO

Carly Behm -   Print  |

Eric Tobin has been announced as CEO of N2 Biomedical, a company providing coating and surface treatment for medical devices, according to a Dec. 2 press release.

Mr. Tobin was previously N2 Biomedical's COO, the release said. He has more than 30 years of experience with the company and its corporate parent.

"I am truly honored that the Board has selected me to assume the CEO position and am excited about the prospects for the company's future," Mr. Tobin said in the release. "We have a dedicated and talented staff, a great foundation of core technologies, and a solid customer base. I look forward to working with the Board and Ampersand to continue providing our customers with the high level of service that they've come to expect from us while also building upon our numerous strengths as a company and capitalizing on growth opportunities."

Read the full press release here.

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers